Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS-Reference-Cited by-同舟云学术

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

Published:2020-01-22 Issue:2 Volume:62 Page:156-166
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Goyal Namita A.¹,Berry James D.²,Windebank Anthony³,Staff Nathan P.³,Maragakis Nicholas J.⁴,Berg Leonard H.⁵,Genge Angela⁶,Miller Robert⁷,Baloh Robert H.⁸,Kern Ralph⁹,Gothelf Yael⁹,Lebovits Chaim⁹,Cudkowicz Merit²

Affiliation:

1. University of California Irvine California

2. Healey Center at Massachusetts General Hospital Boston Massachusetts

3. Mayo Clinic Rochester Minnesota

4. Johns Hopkins University Baltimore Maryland

5. University Medical Center Utrecht Utrecht The Netherlands

6. Montreal Neurological Institute and Hospital Montreal, Quebec Canada

7. California Pacific Medical Center San Francisco California

8. Robert H. Baloh, Cedars‐Sinai Medical Center California Los Angeles

9. Brainstorm Cell Therapeutics New York New York

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.26801

Reference84 articles.

1. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

2. Genetics of Amyotrophic Lateral Sclerosis

3. A systematic review of enrichment strategies for current clinical trials. In: Proceedings from the ALS 29th International Symposium on ALS/MND; December 7‐9, 2018; Glasgow;Goyal NA;United Kingdom.

4. Decoding ALS: from genes to mechanism

5. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to motoneuron disease/ALS treatment using non-invasive brain and spinal stimulation: IFCN handbook chapter;Clinical Neurophysiology;2024-02

2. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis;Cells;2024-01-29

3. Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics;Pharmaceuticals;2024-01-25

4. Predicting amyotrophic lateral sclerosis (ALS) progression with machine learning;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-12-05

5. Riluzole-loaded lipid nanoparticles for brain delivery: Preparation, optimization and characterization;Journal of Molecular Liquids;2023-10